Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
5.00
-0.11 (-2.15%)
Jan 13, 2026, 4:27 PM CET
96.46%
Market Cap1.77B
Revenue (ttm)100.00K
Net Income (ttm)-58.91M
Shares Out354.08M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,222,619
Average Volume2,318,963
Open5.08
Previous Close5.11
Day's Range4.96 - 5.08
52-Week Range1.80 - 5.45
Beta0.14
RSI60.98
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.